Review Article

The Role of the Multiple Hormonal Dysregulation in the Onset of “Anemia of Aging”: Focus on Testosterone, IGF-1, and Thyroid Hormones

Table 2

Observational and intervention studies testing the relationship between IGF-1 and hemoglobin and anemia.

Author referenceYearType of surveyPopulationDose/follow-upResults

Observational
De Vita et al. [80]2015Cross-sectional402 m 536 w
>65 y
Negative association between IGF-1 and anemia in men and positive between IGF-1 and Hb in both sexes
Nilsson-Ehle et al. [81]2005Cross-sectional302 m 317 w
70 y
IGF-1 positive predictor of Hb levels regardless of EPO, health status, and sex
Landi et al. [82]2007Cross-sectional85 m 168 w 
mean age 85 y
Higher IGFBP-3 level is associated with higher Hb concentration among older people
Succurro et al. [83] 2011Cross-sectional491 m 548 w
mean age 48 y
IGF-1 is an independent determinant of Hb; lower IGF-1 is associated with anemia
Ureña et al. [84]1992Cross-sectional17 m and w 
mean age 46 y
HD
Positive correlation between IGF-1 and hematocrit, but not with EPO
Kim et al. [85]2007Cross-sectional41 m 36 w
29–86 y
IGF-1 is independently associated with Hb level in DM-CKD patients

Intervention
Sohmiya et al. [86]1998No RCT3 m 5 w
46–83 y
CRF
Infusion rhGH
2 µg/kg/day
7 days
GH treatment increases EPO levels and reticulocyte counts in CRF patients
Chu et al. [87]2001Double-blind RCT19 m and w
>70 y
Infusion rhGH
0.09 µg/kg/week
4 weeks
Low-dose rhGH improves nutritional status and physical function in elderly with protein-energy malnutrition
Iglesias et al. [88]1998Pilot RCT8 m 9 w
30–78 y
HD
rhGH 0.2 IU/kg/day sc
4 weeks
Short-term rhGH administration increases Hb and hematocrit values
Johannsson et al. [89]1999Double-blind RCT14 m 6 w
53–92 y
HD
rhGH 0.6 IU/kg/week sc
6 months
rhGH supplementation produces anabolic effects but does not significantly affect Hb levels

CRF: chronic renal failure
DMn: diabetic nephropathy
HD: hemodialysis
SC: subcutaneously
DM-CKD: chronic kidney disease (CKD) from DM.